Lucyd, Inc (LUCY) vs Soligenix, Inc. (SNGX)
A side-by-side comparison of Lucyd, Inc and Soligenix, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
LUCY
Lucyd, Inc
$0.91HealthcareDelayed quote: Oct 6, 2026, 3:45 PM EDT
SNGX
Soligenix, Inc.
$0.36HealthcareDelayed quote: Oct 6, 2026, 3:49 PM EDT
Total return — LUCY vs SNGX
growth of $100 · dividends reinvested · last 4yLUCY -99.2% (-70.5%/yr)SNGX -99.8% (-79.6%/yr)LUCY compounded faster over this window
LUCY SNGX
LUCY vs SNGX: by the numbers
- •LUCY is the larger company ($6M vs $5M market cap).
- •Both run net losses; SNGX's is the smaller (0.00% vs -225.28% net margin).
Metrics side by side
Valuation
| Metric | LUCY | SNGX |
|---|---|---|
| P/S ratio | 1.68 | N/A |
| P/B ratio | 0.83 | 0.80 |
Profitability
| Metric | LUCY | SNGX |
|---|---|---|
| Gross margin | 22.79% | 0.00% |
| Operating margin | -319.16% | 0.00% |
| Net margin | -225.28% | 0.00% |
| ROE | -111.42% | -154.08% |
| ROIC | -122.15% | -161.69% |
Growth (annualized)
| Metric | LUCY | SNGX |
|---|---|---|
| Revenue CAGR (5Y) | 64.52% | N/A |
| Total return CAGR (5Y) | N/A | -72.72% |
Go deeper
Dig into the metrics
Lucyd ROESoligenix ROELucyd operating marginSoligenix operating marginLucyd revenue growthSoligenix revenue growthLucyd free cash flowSoligenix free cash flow
Lucyd & Soligenix appear in these rankings
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.